Dr. Christoph Naumann, LL.M. (University of Pennsylvania)

Advising Protect Medical Holding GmbH (Protect Medical) on their acquisition of Spanish emergency medical services (EMS) specialist Productos Metálicos del Bages, SL (Promeba).

 Advising NASDAQ-listed CureVac NV on its acquisition of Dutch cancer specialist Frame Therapeutics BV.

Advising French private equity firm Naxicap Partners and its portfolio company myStromer AG on the merger with the Spanish premium e-bike manufacturer Desiknio.

Advising Lautsprecher Teufel (consisting of Teufel Audio GmbH and further Teufel Group companies) and its shareholders on the refinancing of the Teufel Group.

Advising Cygna Labs Group and its group companies on the acquisition of the Diamond IP business from BT (formerly British Telecom).

Advising Naxicap Partners and its portfolio company, the G&D group, on the acquisition of Mainz-based Tritec Electronic AG and Berlin-based LXCO Technologies AG.

Advising M Ventures (Merck KGaA group) on various venture capital investments.*

Advising Naxicap Partners on its acquisition of Berlin-based consumer audio brand Lautsprecher Teufel.*

Advising the founders of Munich-based Köberl Group on their new partnership agreement with European investment management company Gimv, who acquired a majority stake in Köberl.*

Advising German Rheinmetall AG on the joint venture with BAE Systems for a joint British company for the development and production of military vehicles as well as the support business.*

Advising DC-Datacenter-Group GmbH on its new strategic partnership with MVV, an energy company headquartered in Mannheim, Germany.*

Naxicap Partners on its acquisition of Guntermann & Drunck GmbH Systementwicklung, with Frankfurt-based private equity firm Borromin Capital Management being the majority seller.*

Naxicap Partners on its acquisition of German flat roof specialist alwitra.*

U.S.-leader Reaction Biology Corporation (Malvern, Pennsylvania) on the acquisition of German ProQinase GmbH (Freiburg), both early stage drug discovery companies.*